Advanced Hemodynamic Monitoring
Advanced Hemodynamic Monitoring
Clinical Utility
Fluid Imbalance Can Lead to Complications
Hypoperfusion Edema
Organ dysfunction Organ dysfunction
Adverse outcome Adverse outcome
Complications
Optimal
Hypovolemic Overloaded
Volume Load
The Value of Flow-based Parameters
The amount of
blood that is Cardiac output
pumped by the Normal Range divided by the Normal range
heart per unit body surface 2.5-4.0
4.0-8.0 L/min area (BSA).
time, measured L/min/m2
in liters per
minute (l/min).
4
FloTrac Sensor Advanced Hemodynamic Parameters
Stroke Volume
Stroke Volume
Index
The amount of
blood pumped Stroke Volume
by the left divided by the Normal range
Normal Range
ventricle of the body surface 33-47
heart in one 60-100
area (BSA) ml/m²/beat
contraction ml/beat
5
FloTrac Sensor Advanced Hemodynamic Parameters
A measure of
arteriolar
constriction or SVR multiplied
dilation throughout Normal Range by the body Normal Range
the body, calculated 800-1200 dynes- surface area 1970-2390
by dividing the sec/cm5 (BSA) dynes-
blood pressure by sec/cm5/m2
the cardiac output
6
FloTrac Sensor Advanced Hemodynamic Parameters
7
An Individualized Approach to Fluid Administration
Frank-Starling Curve
Give fluid until SV reaches a plateau
value along the Frank-Starling curve
Methods:
10
Fluid Response Simulator – Normal Contractility
11
Fluid Response Simulator – Normal Contractility Post-
Bolus
12
Fluid Response Simulator – Decreased Contractility
13
Fluid Response Simulator – Decreased Contractility
Post-Bolus #1
14
Fluid Response Simulator – Decreased Contractility
Post-Bolus #2
15
Fluid Response Simulator – Decreased Contractility
Post-Bolus #3
16
Fluid Response Simulator -- ECCE
[Link]/ecce
17
Stroke Volume Variation (SVV) Optimization
Guiding Fluid Therapy in Controlled Ventilated Patients
1. Michard, Rational fluid management: dissecting facts from fiction, BJA, Volume 108, Number 3 2012.
2. Benes J, Chytra I, Altmann P, et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective
randomized study.
3. Critical Care. 2010;14:R118.
4. Cecconi M, Fasano N, Langiano N, et al. Goal directed haemodynamic therapy during elective total hip arthrosplasty under regional anaesthesia. Crit Care.
2011;15:R132.
5. Patent WO 2011/094487 A2, Elimination of the Effects of Irregular Cardiac Cycles in the Determination of Cardiovascular Parameters
6. Michard, Changes in Arterial Pressure during Mechanical Ventilation, Anesthesiology 2005; 103:419–28.
7. Fre´de´ric Michard, MD, PhD; and Jean-Louis Teboul, MD, PhD Predicting Fluid Responsiveness in ICU Patients* A Critical Analysis of the Evidence,
critical care review, 2000.
8. McGee, A Simple Physiologic Algorithm for Managing Hemodynamics Using Stroke Volume and Stroke Volume Variation: Physiologic Optimization
Program, J Intensive Care Med 2009; 24; 3522009
9. [Link]
19
Thank you
CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing
information, including indications, contraindications, warnings, precautions and adverse events.
Edwards, Edwards Lifesciences and the stylized E logo, and FloTrac are trademarks of Edwards Lifesciences Corporation or its affiliates.
All other trademarks are the property of their respective owners.
© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-1895 v1.0